Sort
39,280 grants matching “leukemia”
Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy
$419,474Stefanie Geisler · Washington University · R37 · FY2022 · CA
Molecular studies of Noonan syndrome and related disorders
$419,428Bruce D Gelb · Icahn School Of Medicine At Mount Sinai · R01 · FY2008 · HL
Fate of Spermatogonial Stem Cells
$419,409Martin Dym · Georgetown University · R01 · FY2007 · HD
Project 3: Efficacy of MEK Inhibition in Juvenile Myelomonocytic Leukemia
$419,407Kevin M Shannon · Indiana University Indianapolis · U54 · FY2017 · CA
Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy
$419,407Stefanie Geisler · Washington University · R37 · FY2025 · CA
HIV-1 Preintegration Trafficking and Nuclear Localization
$419,378Alan N. Engelman · Dana-Farber Cancer Inst · R01 · FY2008 · AI
HIV-1 Preintegration Trafficking and Nuclear Localization
$419,378Alan N. Engelman · Dana-Farber Cancer Inst · R01 · FY2009 · AI
Functional Genomic Dissection of Refractory Anemia
$419,371Todd R. Golub · Dana-Farber Cancer Inst · R01 · FY2006 · HL
Directing the metabolic fate of CAR T cells
$419,337Carl H. June · University Of Pennsylvania · R01 · FY2019 · CA
Targeting Leukemic Stem Cells
$419,335Daniel G Tenen · Beth Israel Deaconess Medical Center · R01 · FY2011 · CA
A Novel Approach to Molecular Cell Pathologies of Human Down Syndrome and DS-AD
$419,312Jeanne Bentley Lawrence · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · HD
A Novel Approach to Molecular Cell Pathologies of Human Down Syndrome and DS-AD
$419,312Jeanne Bentley Lawrence · Univ Of Massachusetts Med Sch Worcester · R01 · FY2017 · HD
Complement and T Cell Mediated Allograft Rejection
$419,259Peter Scott Heeger · Icahn School Of Medicine At Mount Sinai · R01 · FY2009 · AI
Expanding the GoT toolkit to link single-cell clonal genotypes with protein, transcriptomic, epigenomic and spatial phenotypes
$419,174Dan Landau · Weill Medical Coll Of Cornell Univ · R33 · FY2022 · CA
Central tolerance mechanisms in B-cell malignancies
$419,150Markus Mãschen · Yale University · R01 · FY2022 · CA
Bmi-1 and Skin Cancer Prevention
$419,142Richard L Eckert · University Of Maryland Baltimore · R01 · FY2009 · CA
Endogenous Heterogeneity of Signaling Pathways in Cancer
$419,127Gregoire Altan-Bonnet · Sloan-Kettering Inst Can Research · U54 · FY2013 · CA
Personalized Risk-AdaptIve Surveillance strategies in cancEr -- PRAISE
$419,114Aasthaa Bansal · University Of Washington · R37 · FY2022 · CA
Control of Erythroid Cell Division and Differentiation
$419,065Albert Einstein Col Of Med Yeshiva Univ · R01 · FY2004 · HL
Arsenic Trioxide in Primary Curative APL Therapy
$419,060Steven D Gore · Johns Hopkins University · R01 · FY2007 · CA
Determinants of epigenetic inheritance in human stem cell fate decisions
$419,039Thelma Escobar · University Of Washington · R35 · FY2023 · GM
Biochemistry and Regulation of V(D)J Recombination
$419,005Mark S. Schlissel · University Of California Berkeley · R37 · FY2010 · AI
APOBEC3G/CEM15 Inhibition of Lentivirus Replication
$418,950Salk Institute For Biological Studies · R01 · FY2005 · AI
APOBEC3G/CEM15 Inhibition of Lentivirus Replication
$418,950Salk Institute For Biological Studies · R01 · FY2004 · AI
The role of CEACAM1 in oncogenic B-cell receptor signaling and immunotherapy in mantle cell lymphoma
$418,946Vu Nguyen Ngo · Beckman Research Institute/City Of Hope · R01 · FY2021 · CA